HC Wainwright & Co. Maintains Buy on Fennec Pharmaceuticals, Raises Price Target to $17

Benzinga · 1d ago
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and raises the price target from $16 to $17.